PCa Blue Founder and CEO John Lupton recently announced that Bayer has been named Founding Corporate Partner of PCa Blue. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life.
Bayer is committed to supporting patients living with advanced prostate cancer and their loved ones. In early 2015, Bayer and an advocacy coalition commissioned the International Prostate Cancer Symptoms Survey, which examined the perspectives of men with advancing prostate cancer and their caregivers on the disease and its symptoms. Survey results showed that nearly 7 in 10 men (68 percent) sometimes ignore the symptoms of prostate cancer, potentially risking their health and delaying further treatment for their advanced disease.
Bayer’s Men Who Speak Up movement brings the symptoms of advancing prostate cancer to life for the community, so that men know when to speak up and take action against their disease. The program raises the collective voices of prostate cancer – the doctors who treat it, the patients and caregivers who live it, and the advocacy groups who support them – and delivers informational tools and resources to those who need them most. For more information, visit www.MenWhoSpeakUp.com.
PCa Blue is pleased to be partners with Bayer in supporting men and their loved ones in better understanding prostate cancer.